First Trust Advisors
LXRX icon

First Trust Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

First Trust Advisors’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-48,986
Closed -$325K – 2435
2018
Q4 		$325K Sell
48,986
-93,927
-66% -$761K ﹤0.01% 2248
2018
Q3 		$1.52M Buy
+142,913
New +$1.64M ﹤0.01% 1802
2017
Q4 		– Sell
-29,256
Closed -$360K – 2433
2017
Q3 		$360K Buy
+29,256
New +$432K ﹤0.01% 2184
2017
Q1 		– Sell
-120,857
Closed -$1.67M – 2427
2016
Q4 		$1.67M Sell
120,857
-4,375
-3% -$70.2K 0.01% 1557
2016
Q3 		$2.26M Buy
125,232
+34,306
+38% +$552K 0.01% 1273
2016
Q2 		$1.3M Buy
+90,926
New +$1.23M ﹤0.01% 1539

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return